TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Elliptic Laboratories ASA
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
11,136
|
6,078
|
4,946 |
| Financial expenses |
390
|
828
|
1,376 |
| Earnings before taxes |
1,439
|
-4,169
|
-3,734 |
| Total assets |
30,477
|
31,129
|
33,186 |
| Current assets |
16,499
|
16,515
|
21,434 |
| Current liabilities |
2,107
|
2,217
|
1,632 |
| Equity capital |
27,464
|
27,321
|
30,934 |
| - share capital |
89
|
93
|
99 |
| Employees (average) | 82 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
90.1%
|
87.8%
|
93.2% |
| Turnover per employee | 136 | ||
| Profit as a percentage of turnover |
12.9%
|
-68.6%
|
-75.5% |
| Return on assets (ROA) |
6.0%
|
-10.7%
|
-7.1% |
| Current ratio |
783.1%
|
744.9%
|
1313.4% |
| Return on equity (ROE) |
5.2%
|
-15.3%
|
-12.1% |
| Change turnover |
5,368
|
1,446
|
-241 |
| Change turnover % |
93%
|
31%
|
-5% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.